MDMA-facilitated cognitive-behavioural conjoint therapy for posttraumatic stress disorder: an uncontrolled trial

Cognitive-behavioural conjoint therapy (CBCT) for PTSD has been shown to improve PTSD, relationship adjustment, and the health and well-being of partners. MDMA (3,4-methylenedioxymethamphetamine) has been used to facilitate an individual therapy for PTSD. This study was an initial test of the safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Monson, Candice M., Wagner, Anne C., Mithoefer, Ann T., Liebman, Rachel E., Feduccia, Allison A., Jerome, Lisa, Yazar-Klosinski, Berra, Emerson, Amy, Doblin, Rick, Mithoefer, Michael C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748057/
https://www.ncbi.nlm.nih.gov/pubmed/33408811
http://dx.doi.org/10.1080/20008198.2020.1840123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748057/
https://www.ncbi.nlm.nih.gov/pubmed/33408811
http://dx.doi.org/10.1080/20008198.2020.1840123

Ejemplares similares